< Back to previous page
Researcher
Cleo Keppens
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Biomedical Quality Assurance Research Unit (Division)
Member
From15 Sep 2014 → 1 Sep 2020
Projects
1 - 1 of 1
- Quality improvement tools for predictive testing in pathologyFrom11 Sep 2015 → 28 Aug 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 22
- Quality improvement tools for predictive testing in pathology(2020)
Authors: Cleo Keppens, Els Dequeker, Ed Schuuring
Number of pages: 398 - Implementation of Novel Methods, Markers or Sample types inMolecular Pathology – Quality Assurance Aspects(2020)
Authors: Cleo Keppens, Els Dequeker
Pages: 302 - 324 - External Quality Assessment Schemes for Biomarker Testing in Oncology Comparison of Performance between Formalin-Fixed, Paraffin-Embedded-Tissue and Cell-Free Tumor DNA in Plasma(2020)
Authors: Cleo Keppens, Els Dequeker
Pages: 736 - 747 - Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples(2020)
Authors: Cleo Keppens, Els Dequeker, Kelly Dufraing
Pages: 366 - 377 - Evolution of RAS testing over time: factors influencing mutation rates in metastatic colorectal cancer patients(2020)
Authors: Kelly Dufraing, Cleo Keppens, Sara Vander Borght, Els Dequeker
- Two years of BRCA1 and BRCA2 somatic external quality assessment with Gen&Tiss scheme in France(2019)
Authors: Kelly Dufraing, Céline Garrec, Caroline Egele, Cleo Keppens, Jean Chiesa, Aude Lamy, Ludovic Lacroix, Alexandre Harlé, R Pascal, Kaat Van Casteren, et al.
- Variation in nomenclature of somatic variants for selection of oncological therapies: can we reach a consensus soon?(2019)
Authors: Cleo Keppens, Véronique Tack, Kelly Dufraing, Els Dequeker
Pages: 7 - 16 - Pre-Analytical Challenges during RAS Testing: Tissue Quality and the Estimation of Neoplastic Cell Percentage(2019)
Authors: Kelly Dufraing, Cleo Keppens, Bert Siebers, George Kafatos, Kimberly Lowe, Gaston Demonty, Els Dequeker, Han van Krieken
Pages: 1 - 1 - IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.(2019)
Authors: Els Dequeker, Cleo Keppens
Pages: 681 - 689 - European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects(2019)
Authors: Cleo Keppens, Kelly Dufraing, Els Dequeker
Pages: 25 - 37